Use your antibodies-online credentials, if available.
No Products on your Comparison List.
Your basket is empty.
Find out more
Show all species
Show all synonyms
Select your species
These data support the hypothesis that the Ox40/Ox40L (show TNFSF4 ELISA Kits) pathway drives cellular and humoral autoimmune responses during lupus nephritis in NZB/W F1 mice and emphasize the potential clinical value of targeting this pathway in human lupus.
OX40 is a death receptor for invariant natural killer T cells and is implicated in pyroptotic cell death.
this study shows that OX40 links a costimulatory receptor to a repressive chromatin remodeling pathway, and that that OX40 stimulation inhibits IL-17 (show IL17A ELISA Kits) and reduces experimental autoimmune encephalomyelitis
IFNalphaR1 signaling promoted CXCL9 (show CXCL9 ELISA Kits) and CXCL10 (show CXCL10 ELISA Kits) synthesis, suggesting that these chemokines might be involved in the LPS (show TLR4 ELISA Kits) and CD134 costimulation response.
OX40 and ICOS (show ICOS ELISA Kits) act in a cooperative, nonredundant manner to maximize and prolong the T follicular helper cell response that is generated after acute virus infection
OX40 regulates cardiac remodelling via the modulation of CD4 (show CD4 ELISA Kits)(+) T-lymphocytes.
bone marrow-derived mast cell (BMMC)-exosomes facilitated the differentiation of naive CD4 (show CD4 ELISA Kits)+ T cells to Th2 cells by ligation of OX40L (show TNFSF4 ELISA Kits) and OX40 between BMMC-exosomes and CD4 (show CD4 ELISA Kits)+ T cells and represents a novel mechanism of cell-to-cell communication
Crystal structures and NMR data show that the Roquin (show RC3H1 ELISA Kits)-1 ROQ domain recognizes hexaloops in the SELEX-derived alternative decay element (ADE) and in an ADE-like variant present in the Ox40 3'-UTR (show UTS2R ELISA Kits) with identical binding modes.
The OX40-OX40 ligand (show TNFSF4 ELISA Kits) interaction up-regulates intracellular levels of reactive oxygen species in atherogenesis.
OX40 was highly expressed by intratumoral T cells, particularly those of the FoxP3 (show FOXP3 ELISA Kits)(+) regulatory T-cell (Treg) lineage.
Metabolically active CD4 (show CD4 ELISA Kits)+ T cells expressing Glut1 (show SLC2A1 ELISA Kits) and OX40 preferentially harbor HIV during in vitro infection.
OX40 and OX40L (show TNFSF4 ELISA Kits) formed a functional complex, which may facilitate signal transduction from OX40L (show TNFSF4 ELISA Kits) to OX40 and contribute to the pathogenesis of Grave's disease.
this study investigated whether CD134 is preferentially expressed on CD4 (show CD4 ELISA Kits) T cells in drug-induced hypersensitivity syndrome .
blocking of both OX-40L (show TNFSF4 ELISA Kits) and 4-1BBL (show TNFSF9 ELISA Kits) reversed radiation-enhanced T-cell killing of human tumor targets as well as T-cell survival and activation.
Low OX40 expression is associated with colorectal cancer.
OX40 and its ligand are co stimulators for T lymphocytes.
These studies provide the first direct evidence that ligation of tumour necrosis factor (show TNF ELISA Kits) superfamily members and their cognate receptors is important for the control of viral lytic replication.
Malaria patients and Plasmodium-infected rodents exhibit enhanced expression of the co-stimulatory receptor OX40 on CD4 (show CD4 ELISA Kits) T cells, which is abrogated following coordinate PD-1 (show PDCD1 ELISA Kits) co-inhibitory pathways, which are also upregulated during malaria.
Identified two key amino acid residues within CD134 that are required for its interaction with herpesvirus 6B (HHV-6B) and for HHV-6B entry into cells. One of the residues (K79) allows access of the HHV-6B ligand to CD134.
TL1A (show TNFSF15 ELISA Kits) increases expression of CD25 (show IL2RA ELISA Kits), LFA-1 (show ITGAL ELISA Kits), CD134 and CD154 (show CD40LG ELISA Kits), and induces IL-22 (show IL22 ELISA Kits) and GM-CSF (show CSF2 ELISA Kits) production from effector CD4 (show CD4 ELISA Kits) T-cells
The protein encoded by this gene is a member of the TNF-receptor superfamily. This receptor has been shown to activate NF-kappaB through its interaction with adaptor proteins TRAF2 and TRAF5. Knockout studies in mice suggested that this receptor promotes the expression of apoptosis inhibitors BCL2 and BCL2lL1/BCL2-XL, and thus suppresses apoptosis. The knockout studies also suggested the roles of this receptor in CD4+ T cell response, as well as in T cell-dependent B cell proliferation and differentiation.
tumor necrosis factor receptor superfamily, member 4
, tumor necrosis factor receptor superfamily member 4
, OX40 antigen
, OX40L receptor
, tax-transcriptionally activated glycoprotein 1
, ACT35 antigen
, ATC35 antigen
, CD134 antigen
, OX40 cell surface antigen
, OX40 homologue
, TAX transcriptionally-activated glycoprotein 1 receptor
, lymphoid activation antigene ACT35
, tax-transcriptionally activated glycoprotein 1 receptor
, MRC OX40
, Tax-transcriptionally activated glycoprotein 1
, tumor necrosis factor (ligand) superfamily member 4
, tumor necrosis factor superfamily, member 4